Heartsciences' myovista® wavecgtm selected for heart screening of irish garda national police officers

Southlake, texas, nov. 13, 2023 (globe newswire) -- heart test laboratories, inc.  d/b/a heartsciences (nasdaq: hscs; hscsw) (“heartsciences” or the “company”), an ai-powered medical technology company focused on transforming ecgs/ekgs to save lives through earlier detection of heart disease, today announced that its myovista® wavecgtm has been selected by cardiact ltd (“cardiact”) to be used in its heart screening program of members of the association of garda sergeants and inspectors (“agsi”).  in addition to the purchase of a myovista® device, cardiact has placed an initial supplies order covering 2,400 patient tests.
HSCS Ratings Summary
HSCS Quant Ranking